Show simple item record

dc.contributor.authorSmyth, Elizabeth C
dc.contributor.authorFitzgerald, Rebecca C
dc.date.accessioned2018-09-27T14:13:01Z
dc.date.available2018-09-27T14:13:01Z
dc.date.issued2018-12-01
dc.identifier.issn2374-2437
dc.identifier.urihttps://www.repository.cam.ac.uk/handle/1810/282847
dc.description.abstractGastric cancer is a global health problem; although incidence rates are declining, it remains the third most common cause of cancer death worldwide. Patients with advanced disease have limited treatment options, and most will live for less than 2 years. Therefore, exploration of gastric cancer disease biology is warranted to identify new targets for treatment. Recent comprehensive molecular analyses have identified distinct subgroups of gastric cancer that may have therapeutic relevance. With the exception of microsatellite-unstable tumors, however, the potential for genomically guided therapy has not been realized.
dc.format.mediumPrint
dc.languageeng
dc.publisherAmerican Medical Association (AMA)
dc.subjectHumans
dc.subjectNeoplasms
dc.subjectMembrane Proteins
dc.subjectCA-125 Antigen
dc.subjectPrognosis
dc.subjectMutation
dc.titleMUC16 Mutations and Prognosis in Gastric Cancer: A Little Goes a Long Way.
dc.typeArticle
prism.endingPage1699
prism.issueIdentifier12
prism.publicationDate2018
prism.publicationNameJAMA Oncol
prism.startingPage1698
prism.volume4
dc.identifier.doi10.17863/CAM.30211
dcterms.dateAccepted2018-06-19
rioxxterms.versionofrecord10.1001/jamaoncol.2018.2803
rioxxterms.licenseref.urihttp://www.rioxx.net/licenses/all-rights-reserved
rioxxterms.licenseref.startdate2018-12
dc.contributor.orcidFitzgerald, Rebecca [0000-0002-3434-3568]
dc.identifier.eissn2374-2445
rioxxterms.typeJournal Article/Review
pubs.funder-project-idMRC (unknown)
pubs.funder-project-idMedical Research Council (MC_UU_12022/2)
cam.issuedOnline2018-08-09
rioxxterms.freetoread.startdate2019-08-09


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record